Startups
Edit
3-V Biosciences
http://www.3vbio.com/Last activity: 06.07.2021
Active - Reference to Sagimet Biosciences
Sagimet Biosciences better reflects our expertise in fatty acid metabolism and current focus on developing ground-breaking therapeutics to treat the liver disease NASH.
Overview
Employees
11-50
Total raised
$68.5M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jun 22, 2013 | Series C round | $20M | |
| Jan 5, 2012 | Funding round | $20M |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| 2015 | 3-V Biosciences Closes $28.5M in Series D Funding | 3-V Biosciences, a Menlo Park, Calif.-based biopharmaceutical company, closed $28.5m in Series D funding. The round was led by New Enterprise Associates, Kleiner Perkins Caufield & Byers and Rock Springs Capital Management with particip... |
| Jun 22, 2013 | 3-V Biosciences Completes $20M Series C Financing | 3-V Biosciences, Inc., a Menlo Park, California-based biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious disease, completed a $20m Series C financing round. Backers included existing inve... |
| Jan 5, 2012 | 3-V Biosciences Picks Up $20M | MENLO PARK, CA, 3-V Biosciences announced both the closing of a Preferred Stock financing and the designation of a novel program targeting a host-factor for the treatment of Hepatitis C virus. >> Click here for more funding data on... |
| Jan 5, 2012 | 3-V Biosciences Closes $20M Financing | 3-V Biosciences, Inc. a Menlo Park, California-based biopharmaceutical company dedicated to discovering, developing and commercializing novel antiviral therapeutics that target host cell factors required for viral infection, closed a $20m f... |
Reviews 0
FAQ about 3-V Biosciences
How much funding has 3-V Biosciences raised?
3-V Biosciences has raised $68.5M in total across 3 funding rounds.
What funding rounds has 3-V Biosciences raised?
Parsers VC lists 3 funding rounds of 3-V Biosciences, among them a Series C round of $20M on Jun 22, 2013 and a funding round of $20M on Jan 5, 2012.
What has the press written about 3-V Biosciences?
Parsers VC has collected 5 articles mentioning 3-V Biosciences, among them “3-V Biosciences Closes $28.5M in Series D Funding” (2015) and “3-V Biosciences Completes $20M Series C Financing” (Jun 22, 2013).
Is 3-V Biosciences still active?
Yes, 3-V Biosciences is active; its latest activity on Parsers VC dates from Jul 6, 2021.